Bi‐Cheng Liu

机构：Zhongda Hospital Southeast University · ORCID：0000-0002-4584-1853

发表论文 468 篇 · 总被引 18726 次 · h-index 62

代表论文

• Single urinary extracellular vesicle proteomics identifies complement receptor CD35 as a biomarker for sepsis-associated acute kidney injury (2025 · Nature Communications · 被引 30)
• A comprehensive evaluation of stability and safety for HEK293F-derived extracellular vesicles as promising drug delivery vehicles (2025 · Journal of Controlled Release · 被引 29)
• Comprehensive Comparison of Extracellular Vesicles Derived from Mesenchymal Stem Cells Cultured with Fetal Bovine Serum and Human Platelet Lysate (2025 · ACS Nano · 被引 16)
• Kidney hepcidin protects the collecting duct against ferroptosis in ischemia/reperfusion-induced acute kidney injury (2025 · Kidney International · 被引 10)
• Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial (2025 · BMJ · 被引 6)
• Efficacy and safety of HSK21542 for pruritus management in hemodialysis patients: a multicenter, randomized, double-blind, placebo-controlled trial (2025 · Frontiers in Pharmacology · 被引 6)